Palla Pharma (ASX:PAL) EPS (Basic) : A$-0.42 (TTM As of Jun. 2021)

View and export this data going back to 2015. Start your Free Trial

What is Palla Pharma EPS (Basic)?

Palla Pharma's basic earnings per share (Basic EPS) for the six months ended in Jun. 2021 was A$-0.22. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2021 was A$-0.42.

Palla Pharma's EPS (Diluted) for the six months ended in Jun. 2021 was A$-0.22. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2021 was A$-0.42.

Palla Pharma's EPS without NRI for the six months ended in Jun. 2021 was A$-0.22. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2021 was -0.42.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Palla Pharma EPS (Basic) Historical Data

The historical data trend for Palla Pharma's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Palla Pharma EPS (Basic) Chart

Palla Pharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

EPS (Basic)

Get a 7-Day Free Trial

-0.24

-0.21

-0.06

-0.08

-0.26

Palla Pharma Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21
EPS (Basic)	Get a 7-Day Free Trial							-0.05	-0.04	-0.07	-0.19	-0.22

Palla Pharma EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Palla Pharma's Basic EPS for the fiscal year that ended in Dec. 2020 is calculated as

Basic EPS (A: Dec. 2020 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-34.756	-	0)	/	132.452
	=	-0.26

Palla Pharma's Basic EPS for the quarter that ended in Jun. 2021 is calculated as

Basic EPS (Q: Jun. 2021 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-33.106	-	0)	/	147.661
	=	-0.22

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2021 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.42

Palla Pharma (ASX:PAL) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Palla Pharma EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Palla Pharma's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Palla Pharma (ASX:PAL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Palla Pharma Ltd (ASX:PAL) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/- Mertons Corporate Services, 330 Collins Street, Level 7, Melbourne, VIC, AUS, 3000

Website

http://www.tpienterprises.com

Palla Pharma Ltd is a licensed poppy processor in Australia. It is engaged in producing narcotic raw material for the international pharmaceutical industry. It also supplies narcotic raw material and culinary poppy seed.

Palla Pharma (ASX:PAL) Headlines

From GuruFocus

Proficient Auto Logistics Announces Pricing of Initial Public Offering

By Business Wire • 05-09-2024